Weiwei Tan
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 30
- Advanced Breast Cancer Therapies 5
- Oncology 27
- Colorectal Cancer Treatments and Studies 13
- HER2/EGFR in Cancer Research 7
- Lung Cancer Research Studies 5
- Co-authors
- Keith D. Wilner (17 shared papers)Zhongzhou Shen (2 shared papers)Susumu Kobayashi (1 shared paper)Wee-Lee Yeo (1 shared paper)Shuchi S. Pandya (1 shared paper)Daniel B. Costa (1 shared paper)Benjamin Solomon (4 shared papers)D. Ross Camidge (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (3 papers)Future Oncology (3 papers)Cancer Research (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Weiwei Tan
55 papers receiving 1.9k citations
Weiwei Tan's Hit Papers
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 790
- Hepatology 103
- Cancer Research 179
- Molecular Biology 729
Countries citing papers authored by Weiwei Tan
This map shows the geographic impact of Weiwei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Tan more than expected).
Fields of papers citing papers by Weiwei Tan
This network shows the impact of papers produced by Weiwei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Tan. The network helps show where Weiwei Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib Hit paper breakdown → | 2011 | 487 |
| 2 | 2011 | 351 | |
| 3 | 2010 | 208 | |
| 4 | 2012 | 106 | |
| 5 | 2010 | 49 | |
| 6 | 2014 | 47 | |
| 7 | 2015 | 45 | |
| 8 | 2017 | 45 | |
| 9 | 2016 | 41 | |
| 10 | 2010 | 41 | |
| 11 | 2014 | 37 | |
| 12 | 2011 | 37 | |
| 13 | 2005 | 34 | |
| 14 | 2019 | 32 | |
| 15 | 2022 | 27 | |
| 16 | 2015 | 27 | |
| 17 | 2019 | 26 | |
| 18 | 2021 | 22 | |
| 19 | 2016 | 21 | |
| 20 | 2018 | 21 |
About Weiwei Tan
Weiwei Tan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Epidemiology, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Colorectal Cancer Treatments and Studies (13 papers), HER2/EGFR in Cancer Research (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Advanced Breast Cancer Therapies (5 papers), Lung Cancer Research Studies (5 papers), Protein Degradation and Inhibitors (4 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Oncology (790 citations), Hepatology (103 citations), Cancer Research (179 citations) and Molecular Biology (729 citations). Weiwei Tan has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Keith D. Wilner, Zhongzhou Shen, Susumu Kobayashi, Wee-Lee Yeo, Shuchi S. Pandya, Daniel B. Costa, Benjamin Solomon, D. Ross Camidge, Sai‐Hong Ignatius Ou and Ravi Salgia. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Future Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.